Bell, RM;
Yellon, DM;
(2017)
SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection.
The Lancet Diabetes & Endocrinology
10.1016/S2213-8587(17)30314-5.
(In press).
Preview |
Text
Bell_Commentary - SGLT2.pdf - Accepted Version Download (515kB) | Preview |
| Type: | Article |
|---|---|
| Title: | SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S2213-8587(17)30314-5 |
| Publisher version: | http://doi.org/10.1016/S2213-8587(17)30314-5 |
| Language: | English |
| Additional information: | © 2017 Elsevier Ltd. All rights reserved. This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10025820 |
Downloads since deposit
567Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
